VAPAWAY.EU - Research and education on VAP prevention
  • Home
  • Articles
  • GuideLines
  • Links
  • About VAPAWAY
  • Training
  • Contacts

Login








Lost Password?

Register to receive updated data on VAPAWAY initiative

Agenda

 

9 - 12 March 2010

ISICEM International Symposium on Intensive Care and Emergency Medicine - Brussels (Belgium)

ISICEM

 

9 -11 June 2010

EACTA European Association of Cardiothoracic Anaesthesiologists - Edinburgh (UK)

EACTA

 

12-15 June 2010

ESA European Society of Anaesthesiology - Helsinki (Finland)

ESA

 

18-22 September 2010

ERS European Respiratory Society - Barcellona (Spain)

ERS

 

9 -13 October 2010

ESICM European Society of Intensive Care Medicine - Barcellona (Spain)

ESICM

  

 

> International events   

> Local events 

test


PHARMACOKINETICS AND PHARMACODYNAMICS OF LEVOFLOXACIN IN CRITICALLY ILL PATIENT WITH VAP PDF Print E-mail
Wednesday, 16 January 2008

Benko R., et al.

About this article: "Levofloxacin is an antibiotic recently recommended for the treatment of late VAP. This study investigates the PK/PD characteristics of  Levofloxacin in 11 patients with VAP. The study recommend the dosage of 500 mg /12 h but even with these dosages treatment failure have to be taken into account."

Last Updated ( Thursday, 14 February 2008 )
Read more...
 
OPTIMAL MANAGEMENT THERAPY FOR PSEUDOMONAS AERUGINOSA VAP PDF Print E-mail
Wednesday, 16 January 2008

Garnacho-Montero J., et al.

About this article: "This retrospective study suggests that combination therapy is not necessary for the treatment of Pseudomonas aeruginosa pneumonia. In fact, the most important protective factor for clinical cure and mortality was the adequacy of initial antibiotic therapy."

Last Updated ( Thursday, 14 February 2008 )
Read more...
 
EARLY EXPERIENCE WITH TIGENCYCLINE X VAP AND BACTEREMIA CAUSED BY MULTIDRUG-RESIST ACINETOBACTER PDF Print E-mail
Wednesday, 16 January 2008

Schafer JJ, et al.

About this article: "This article reports the experience of 25 cases of  A.baumanii VAP  multiresistant to antibiotics and sensitive to tygecycline. Patients were treated with combination or in 5 cases with tygecycline alone. Tygecycline resulted clinically effective in most of then 25 cases.Tigecycline is a good antibiotic option for the treatment of VAP caused by A.baumanii multiresistant."

Last Updated ( Thursday, 14 February 2008 )
Read more...
 
THE ROLE OF AEROSOLIZED ANTIMICROBIALS IN THE TREATMENT OF VAP PDF Print E-mail
Wednesday, 16 January 2008

Dhand R.

About this article: "This is a review article on aerosolized antibiotics in the prevention of VAP. One of the major conclusions is that the medications for aerosolized antibiotics in VAP need more randomized studies."

Last Updated ( Thursday, 14 February 2008 )
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 Next > End >>

Results 64 - 67 of 67
Select and watch
from the following webinars

 


Join us on www.smartonweb.org

Partner

VAPAWAY is proudly supported by Covidien.

http://www.covidien.com